Resources

Get helpful information about MRD and M-inSight®

All
Articles
Documentation
Events
Posters
Publications
decoration
Articles
06/29/2023

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration - Clin Cancer Res. 2021

Articles
06/29/2023

Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications - Front Oncol. 2022

Articles
06/29/2023

Extramedullary disease in multiple myeloma: a systematic literature review - Blood Cancer J. 2022

Articles
06/29/2023

Modern Myeloma Therapy + Sustained Minimal Residual Disease-Negative = (Functional) Cure! - Journal of Clinical Oncology, 2022

Articles
06/08/2023

Mass spectrometry for the evaluation of monoclonal proteins in MM and related disorders - Blood Cancer J. 2021

ABOUT M-inSight®

Ultra sensitive, Personalized MRD testing in Blood